Raymond James Financial’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$381M Buy
775,318
+14,675
+2% +$7.96M 0.12% 144
2025
Q4
$441M Buy
760,643
+10,814
+1% +$6.12M 0.14% 120
2025
Q3
$364M Sell
749,829
-28,993
-4% -$13.5M 0.12% 142
2025
Q2
$316M Buy
778,822
+53,542
+7% +$22.4M 0.11% 170
2025
Q1
$361M Sell
725,280
-1,132
-0.2% -$613K 0.14% 134
2024
Q4
$378M Buy
+726,412
New +$399M 0.14% 126

Other funds holding TMO

Raymond James Financial's TMO Position: Q1 2026 in Review

Raymond James Financial increased its Thermo Fisher Scientific (TMO) stake by 1.9% in Q1 2026, buying an estimated $7.96M and bringing the position to 775,318 shares worth $381M. The position accounts for 0.12% of the portfolio, ranked #144.

Raymond James Financial first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $441M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Raymond James Financial held 775,318 shares of Thermo Fisher Scientific worth $381M as of Q1 2026.
  • Raymond James Financial bought 14,675 Thermo Fisher Scientific shares in Q1 2026, an estimated $7.96M.
  • Thermo Fisher Scientific made up 0.12% of Raymond James Financial's portfolio in Q1 2026, its #144 holding.
  • Raymond James Financial first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Thermo Fisher Scientific position peaked at $441M in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.